Joseph A. Kotarek

Subvisible Particle Content, Formulation, and Dose of an Erythropoietin Peptide Mimetic Product Are Associated With Severe Adverse Postmarketing Events

Joseph A. Kotarek, Christine Stuart, Silvia H. De Paoli et al. · Journal of Pharmaceutical Sciences · 2016 · 115 citations · Full text

Medicine, Pharmacotherapy, Pharmacology +1

Analyzing Subvisible Particles in Protein Drug Products: a Comparison of Dynamic Light Scattering (DLS) and Resonant Mass Measurement (RMM)

Jainik Panchal, Joseph A. Kotarek, Ewa Marszal et al. · The AAPS Journal · 2014 · 99 citations · Full text

Dynamic Light Scattering, Biochemistry, Subvisible Particles +10

Soluble aggregates of the amyloid‐β protein selectively stimulate permeability in human brain microvascular endothelial monolayers

Francisco J. Gonzalez‐Velasquez, Joseph A. Kotarek, Melissa A. Moss · Journal of Neurochemistry · 2008 · 65 citations · Full text

Quartz crystal microbalance analysis of growth kinetics for aggregation intermediates of the amyloid-β protein

Joseph A. Kotarek, Kathryn C. Johnson, Melissa A. Moss · Analytical Biochemistry · 2008 · 60 citations

Colloidal Material, Amyloid-β Protein, Engineering +10

Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model

Ehab M. Moussa, Joseph A. Kotarek, Jodi Switzer Blum et al. · Pharmaceutical Research · 2016 · 33 citations

Inflammation, Vitro Cell-based Model, Allergy +12